GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.7510
+0.0120 (1.62%)
At close: Aug 14, 2025, 4:00 PM
0.7398
-0.0112 (-1.49%)
After-hours: Aug 14, 2025, 4:15 PM EDT
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $19.05 million as of August 14, 2025. Its market cap has increased by 65.16% in one year.
Market Cap
19.05M
Enterprise Value
15.79M
1-Year Change
65.16%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since May 13, 2019, GeoVax Labs's market cap has increased from $1.04M to $19.05M, an increase of 1,724.28%. That is a compound annual growth rate of 59.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 18.74M | -19.59% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.01% |
| Dec 31, 2020 | 12.03M | 6,734.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |